A new type of medicine that targets RNA was discovered by accident and could change the way some diseases are treated.

Inside the hunt for new antivirals to combat the current pandemic and to prepare for future ones.

Researchers from Seattle Children’s and Novartis shed light on developmental brain disorders that lead to intractable epilepsy.

A diminutive protein prompts a closer look at DNA dark matter.

Discovery points toward treatment options beyond insulin injections

The leaders behind the Novartis Innovation Lab share how they are leveraging emerging technologies to win for patients.

Jay Bradner discusses his vision for an open framework of scientific discovery at Novartis.

Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world.